Dr. Dominic Helm
Head of Proteomics Core Facility, DKFZ Heidelberg
Role in LiSyM-Cancer
- Partner in SMART-NAFLD
- Contributes access to core facility infra-structure
- Enable harmonization of clinical proteomics
- Expand the measurement capacities necessary for the analysis of large clinical cohorts
Expertise
- Expert in mass spectrometry-based prote-omics, with a strong background in method development and application specifically focusing on large scale and high-throughput experimental set-ups
Degrees
- 2012 – 2015, PhD Mass spectrometry based chemical proteomics for drug selectivity profiling, Technical University of Munich
- 2009 – 2011, Master of Science (M.Sc.), Molecular Biotechnology,Technical University of Munich
- 2006 – 2009, Bachelor of Science (B.Sc.), Biochemistry, Ulm University
Professional Experience
- Since 2025, Director Proteomics Core Facility, MD Anderson Cancer Center, Houston, Texas, United States
- 2020 – 2025, Head of Proteomics Core Facility, DKFZ German Cancer Research Center, Heidelberg
- 2016 – 2020, Senior Mass Spectrometrist in the Proteomics Core Facility at EMBL, Heidelberg
- 2015, Research Scientist at OmicScouts GmbH